Diploid SRM
Source: Thermo Fisher Scientific
Significantly higher productivity leads to higher virus production
Human cells have been used to manufacture a variety of vaccines such as varicella-zoster, polio, smallpox, hepatitis A, measles, mumps and rubella. Traditionally, the only way to culture these cells has been to utilize classical media with 10% serum, one of the highest-cost components in the vaccine process. Human and recombinant human albumin, which is traditionally used in virus production media, also tends to be expensive.
Click here for more information
Diploid SRM helps with the reduction or elimination of both while maintaining high virus titers for vaccine production (Figure 2).
Thermo Fisher Scientific
This website uses cookies to ensure you get the best experience on our website. Learn more